Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients

Nephrology Dialysis Transplantation

Volumn 21, Issue 12, 2006, Pages 3532-3538

  Banche, Giuliana ^a   Allizond, Valeria ^a   Giacchino, Franca ^b   Mandras, Narcisa ^a   Roana, Janira ^a   Bonello, Franco ^b   Belardi, Paola ^b   Tullio, Vivian ^a   Merlino, Chiara ^a   Carlone, Nicola ^a   Cuffini, Anna Maria ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale Civile   (Italy)

Author keywords

Chronic renal insufficiency; Dialysis membrane; Human polymorphonuclear cells; Intracellular killing; Klebsiella pneumoniae; Phagocytosis

Indexed keywords

CELLULOSE; POLYSULFONE;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; BIOCOMPATIBILITY; CELL ACTIVITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTROLLED STUDY; DIALYSIS MEMBRANE; EVIDENCE BASED MEDICINE; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; MALE; NEPHROSCLEROSIS; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; TREATMENT DURATION;

AGED; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; MALE; MEMBRANES, ARTIFICIAL; NEUTROPHILS; RENAL DIALYSIS;

EID: 33751397461     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl415     Document Type: Conference Paper

References (29)

1. Gastaldello K, Husson C, Wens R et al. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol Dial Transplant 2000; 15: 1638-1646
2. Marewska E, Baj Z, Sulowska Z et al. Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol Dial Transplant 2003; 18: 2582-2588
3. Descamps-Latscha B, Herbelin A, Nguyen AT et al. Dysregulation of the immune system in chronic uraemic and hemodialysed patients. Presse Med 1995; 24: 405-410
4. Cohen G, Rudnicki M, Horl WH. Isolation of modified ubiquitin as a neutrophil chemotaxis inhibitor from uraemic patients. J Am Soc Nephrol 1998; 9: 451-456
5. Reato G, Cuffini AM, Tullio V et al. Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils. Int J Antimicrob Agents 2004; 23: 150-154
6. Cuffini AM, Tullio V, Giacchino F et al. Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic haemodialysis patients. Am J Kidney Dis 2001; 37: 1253-1259
7. Cuffini AM, Tullio V, Giacchino F et al. Improved phagocyte response by co-amoxiclav in renal transplant recipients. Transplantation 2001; 71: 575-577
8. Allon M, Depnert TA, Radeva M et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO STUDY. J Am Soc Nephrol 2003; 14: 1863-1870
9. Rao M, Guo D, Jaber BL et al. Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients. Kidney Int 2004; 65: 682-691
10. Haag-Weber H, Horl WH. The immune system in uremia and during its treatment. New Horiz 1995; 3: 669-679
11. Hakim RM. Clinical implication of biocompatibility in blood purification membranes. Nephrol Dial Transplant 2000; 15: 16-20
12. Walker RJ, Sutherland WHF, De Jong SA. Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers. Clin Nephrol 2004; 61: 198-206
13. Macleod AM, Campbell M, Cody JD et al. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease. Cochrane Data Base Syst Rev 2005; 20: 003234
14. Hoenich NA, Woffindin C, Stamp S et al. Synthetically modified cellulose: An alternative to synthetic membranes for use in haemodialysis? Biomaterials 1997; 18: 1299-1303
15. Bowry SK, Rintelen TH. Synthetically modified cellulose (SMC): A cellulosic hemodialysis membrane with minimized complement activation. ASAIO J 1998; 44: 579-583
16. Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with rheological improvement of circulating red blood cells. Kidney Int 2003; 63: 1881-1887
17. Mydlík M, Derzsiová K, Rácz O et al. A modified dialyzer with vitamin E and antioxidant defence parameters. Kidney Int 2001; 59: 144-147
18. Libetta C, Zucchi M, Gori E et al. Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int 2004; 65: 1-9
19. Satoh M, Yamasaki Y, Nagake Y et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 2001; 59: 1943-1950
20. Ronco C, Fabris A, Feriani M et al. Technical and clinical evaluation of a new synthetic low-flux polysulphone membrane for hemodialysis. Int J Artif Organs 1989; 12: 450-460
21. Vienken J, Bowry S. Quo vadis dialysis membrane? Artif Organs 2002; 26: 152-159
22. Vanholder R, De Smet R, Jacobs V et al. Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. Nephrol Dial Transplant 1994; 9: 1271-1278
23. Anding K, Gross P, Rost JM et al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant 2003; 18: 2067-2073
24. Ward RA, McLeish KR. Polymorphonuclear leukocytes oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1995; 5: 1697-1702
25. Iida T, Umezawa K, Tanaka K et al. Polymorphonuclear cells in chronic haemodialysis patients have intact phagocytotic and impaired bactericidal activities. Nephron 1997; 75:41-47
26. Klein JB, McLeish KR, Ward RA. Transplantation, not dialysis corrects azotemia-depend priming of the neutrophil oxidative burst. Am J Kidney Dis 1999; 33: 483-491
27. Girndt M, Lengler S, Kaul H et al. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis 2000; 35: 95-104
28. Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int 2006; 69: 706-714
29. Morimoto H, Nakao K, Fukuoka K et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialydis patients. Nephrol Dial Transplant 2005; 20: 2775-2782